Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Thorax

• Publication date

  1996-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.51.3.262PMID 8779128PMCID PMC1090636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New perspectives on inhaled drug delivery and systemic bioactivity.

  1995cited by this paper
• New perspectives on inhaled drug delivery and systemic bioactivity

  1995cited by this paper
• High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.

  1995cited by this paper
• High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.

  1994cited by this paper
• An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.

  1994cited by this paper
• A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects.

  1994cited by this paper
• Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.

  1994cited by this paper
• Binding kinetics of fluticasone propionate to the human glucocorticoid receptor.

  1994cited by this paper
• Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction.

  1993cited by this paper
• Comparison offluticasone propionate with beclomethasone dipropionate inmoderate to severeasthma treated for one year

  1993cited by this paper
• Clinical pharmacology of corticosteroids in bronchial asthma.

  1993cited by this paper
• Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.

  1993cited by this paper
• A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma.

  1993cited by this paper
• The human pharmacology of fluticasone propionate.

  1990cited by this paper
• Guidelines for management of asthma.

  1990cited by this paper
• Structure-activity relationships of topically active steroids: the selection of fluticasone propionate.

  1990cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper
• Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.

  1982cited by this paper
• [Bronchial asthma].

  1950cited by this paper

• Reacciones adversas provocadas por corticoides inhalados en asmáticos adultos. Una revisión sistemática

  2025cites this paper
• Paediatric reference range for overnight urinary cortisol corrected for creatinine

  2021cites this paper
• What makes flunisolide different among inhaled corticosteroids used for nebulization: a close look at the role of aqueous solubility

  2021cites this paper
• An occupational exposure limit (OEL) approach to protect home healthcare workers exposed to common nebulized drugs.

  2019cites this paper
• Benefit:Risk Profile of Budesonide in Obstructive Airways Disease

  2019cites this paper
• A Pilot Study of the Normative Range of Overnight Urinary Free Cortisol Corrected for Creatinine in Children

  2018cites this paper
• Metabolomics analysis identifies different metabotypes of asthma severity

  2017cites this paper
• Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis.

  2016cites this paper
• Budesonide/salmeterol in fixed-dose combination for the treatment of asthma

  2016cites this paper
• Adrenal Insufficiency after Chronic Swallowed Glucocorticoid Therapy for Eosinophilic Esophagitis.

  2016cites this paper
• The Benefits of Identifying and Treating Adrenal Suppression in Adult Difficult Asthmatics: A Case Series

  2016cites this paper
• The Wrath of Steroids in Elderly Patients with Pulmonary Diseases

  2016cites this paper
• Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

  2016cites this paper
• Eosinophilic esophagitis: overview of clinical management.

  2014cites this paper
• The changing face of severe childhood asthma: a comparison of two cohorts of children evaluated at National Jewish Health over the past 20 years.

  2014cites this paper
• [A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma].

  2014cites this paper
• Hospitalized patients with COPD: analysis of prior treatment*

  2014cites this paper
• Inhaled corticosteroids in COPD: the clinical evidence

  2014cites this paper
• Switching from systemic steroids to ciclesonide restores the hypothalamic pituitary-adrenal axis

  2014cites this paper
• Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.

  2014cites this paper
• Une nouvelle association fixe de fluticasone/formotérol dans un aérosol-doseur pressurisé pour le traitement de l’asthme

  2014cites this paper
• The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression

  2013cites this paper
• Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis.

  2013cites this paper
• Results of the Patient ’ s Modified Mayo Dysphagia Questionnaire * While on an Improved Diet † After Starting BUD Therapy

  2013cites this paper
• Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study

  2013influential citation
• The effect of intranasal fluticasone propionate irrigations on salivary cortisol, intraocular pressure, and posterior subcapsular cataracts in postsurgical chronic rhinosinusitis patients

  2013cites this paper
• Prospective follow-up of novel markers of bone turnover in persistent asthmatics exposed to low and high doses of inhaled ciclesonide over 12 months.

  2012cites this paper
• Pharmacological treatment of COPD.

  2011cites this paper
• Pharmacological treatment of COPD.

  2011cites this paper
• Treatment of eosinophilic esophagitis: is oral viscous budesonide superior to swallowed fluticasone spray?

  2011cites this paper
• Tratamento farmacológico da DPOC* Pharmacological treatment of COPD

  2011cites this paper
• Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future

  2009cites this paper
• Chapter 16 – Pharmacology of the Lung and Drug Therapy

  2008cites this paper
• Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review.

  2008cites this paper
• Corticotrophins, Corticosteroids and Prostaglandins

  2007cites this paper
• Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.

  2007cites this paper
• In search of the perfect steroid

  2007cites this paper
• Propionate de fluticasone dans l'asthme de l'enfant et du nourrisson

  2007cites this paper
• Efficacy and safety of once‐daily inhaled ciclesonide in adults with mild to moderate asthma: A double‐blind, placebo‐controlled study *

  2007cites this paper
• Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.

  2007cites this paper
• [Fluticasone propionate in children and infants with asthma].

  2007cites this paper
• Intranasal Ciclesonide Coadministration with Inhaled Fluticasone Propionate-Salmeterol does not Suppress Cortisol in Allergic Rhinitis Patients

  2007cites this paper
• Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma *

  2007cites this paper
• A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma.

  2007cites this paper
• Drug Class Review on Inhaled Corticosteroids

  2006cites this paper
• Systemic side effects of inhaled corticosteroids in patients with asthma.

  2006cites this paper
• Two-Dimensional and Three-Dimensional Imaging Show Ciclesonide Has High Lung Deposition and Peripheral Distribution: A Nonrandomized Study in Healthy Volunteers

  2006cites this paper
• Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.

  2005cites this paper
• Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.

  2005cites this paper
• What Does Potency Actually Mean for Inhaled Corticosteroids?

  2005cites this paper
• Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthma

  2005cites this paper
• Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.

  2005cites this paper
• The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children.

  2005cites this paper
• Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review

  2004cites this paper
• Safety of inhaled corticosteroids.

  2004cites this paper
• The Role of Budesonide in Adults and Children with Mild‐to‐Moderate Persistent Asthma

  2004cites this paper
• Pharmacokinetics of inhaled drugs.

  2003cites this paper
• Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.

  2003cites this paper
• Population Pharmacokinetics and Pharmacodynamics of Ciclesonide

  2003cites this paper
• Weighing the risks of treatment versus nontreatment in pediatric asthma.

  2003cites this paper
• Assessment of Adrenal Suppression from Two New Dry Powder Inhaler Formulations of Budesonide Delivered by Clickhaler® Compared with the Pulmicort® Turbuhaler®

  2003cites this paper
• The effect of a steroid "burst" and long-term, inhaled fluticasone propionate on adrenal reserve.

  2003cites this paper
• Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate

  2002cites this paper
• Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.

  2002cites this paper
• Bioavailability of Budesonide Delivered by the Clickhaler® and Turbuhaler® Dry Powder Inhalers in Healthy Volunteers

  2002cites this paper
• Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients.

  2002cites this paper
• Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide.

  2002cites this paper
• Symbicort: controlling asthma in adults.

  2002cites this paper
• Inhaled Steroids: Are They All Created Equal?

  2002cites this paper
• The hardest worker?

  2002cites this paper
• Symbicort@: controlling asthma in adults

  2002cites this paper
• Systemic effect comparisons of six inhaled corticosteroid preparations.

  2002cites this paper
• Fluticasone Propionate via Diskus™ Inhaler at Half the Microgram Dose of Budesonide via Turbuhaler™ Inhaler

  2001cites this paper
• Ciclesonide: An On-Site-Activated Steroid

  2001cites this paper
• Fluticason zur Asthmatherapie im Kindesalter

  2001cites this paper
• Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.

  2001cites this paper
• Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects

  2001cites this paper
• INHALED GLUCOCORTICOIDS, ESTABLISHED AND NEW

  2000cites this paper
• Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.

  2000cites this paper
• Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.

  2000cites this paper
• A Study Comparing the Clinical Pharmacokinetics, Pharmacodynamics, and Tolerability of Triamcinolone Acetonide HFA‐134a Metered‐Dose Inhaler and Budesonide Dry‐Powder Inhaler following Inhalation Administration

  2000cites this paper
• Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease".

  2000cites this paper
• Inhaled and nasal corticosteroids: safety aspects*

  2000cites this paper
• The Role of Cysteinyl Leukotriene Receptor Antagonists in Asthma Therapy

  2000cites this paper
• The Effect of Inhaled Steroids on the Linear Growth of Children With Asthma: A Meta-analysis

  2000cites this paper
• Inhaled Corticosteroids: Maximizing Clinical Benefit in Children with Asthma

  2000cites this paper
• Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.

  1999cites this paper
• Montelukast: Data from Clinical Trials in the Management of Asthma

  1999cites this paper
• Corticosteroid treatment of asthma: now at the crossroads.

  1999cites this paper
• Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.

  1999cites this paper
• A Pharmacokinetic/Pharmacodynamic Approach to Predict the Cumulative Cortisol Suppression of Inhaled Corticosteroids

  1999cites this paper
• Beclomethasone for asthma in children: effects on linear growth.

  1999cites this paper
• Newer therapeutic agents for asthma.

  1999cites this paper
• The Effect of Inhaled Steroids on the Linear Growth of Children with Asthma. A Meta-Analysis

  1999cites this paper
• Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate

  1999cites this paper
• 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids

  1999cites this paper
• Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.

  1999cites this paper
• Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

  1999cites this paper
• The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. National Heart, Lung, and Blood Institute.

  1999cites this paper
• Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.

  1999cites this paper